Hemostemix Inc. (TSXV: HEM)

Hemostemix Statistics

Total Valuation

Hemostemix has a market cap or net worth of CAD 10.54 million. The enterprise value is 15.05 million.

Market Cap	10.54M
Enterprise Value	15.05M

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Hemostemix has 123.98 million shares outstanding. The number of shares has increased by 13.32% in one year.

Current Share Class	n/a
Shares Outstanding	123.98M
Shares Change (YoY)	+13.32%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	20.05%
Owned by Institutions (%)	n/a
Float	98.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.78
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.07

Current Ratio	0.07
Quick Ratio	0.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-349.24%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.43%
50-Day Moving Average	0.09
200-Day Moving Average	0.07
Relative Strength Index (RSI)	48.40
Average Volume (20 Days)	62,356

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.53M
Pretax Income	-1.94M
Net Income	-1.94M
EBITDA	-1.53M
EBIT	-1.53M
Earnings Per Share (EPS)	-0.02

Balance Sheet

The company has 103,752 in cash and 4.62 million in debt, giving a net cash position of -4.51 million or -0.04 per share.

Cash & Cash Equivalents	103,752
Total Debt	4.62M
Net Cash	-4.51M
Net Cash Per Share	-0.04
Equity (Book Value)	-8.36M
Book Value Per Share	-0.10
Working Capital	-3.25M

Cash Flow

Operating Cash Flow	-358,292
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Hemostemix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.32%
Shareholder Yield	-13.32%
Earnings Yield	-25.91%
FCF Yield	n/a

Stock Splits

The last stock split was on December 30, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Dec 30, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a